Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.
|
25087618 |
2014 |
Long Qt Syndrome 11
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutation of an A-kinase-anchoring protein causes long-QT syndrome.
|
18093912 |
2007 |
Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Mutation of an A-kinase-anchoring protein causes long-QT syndrome.
|
18093912 |
2007 |
Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.
|
11799244 |
2002 |
Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.
|
11799244 |
2002 |
Long Qt Syndrome 11
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Long Qt Syndrome 11
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Colorectal Carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we investigated the molecular mechanism by which MALAT1 enhances AKAP9 expression in CRC SW480 cells.
|
26887056 |
2016 |
Colorectal Carcinoma
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Our data indicate that AKAP9 gene harbors not only somatic frameshift mutations but also mutational ITH, which together may be features of GC and CRC with MSI-H. Our results also suggest that regional mutation analysis is needed for a better evaluation of mutation status in these tumors to overcome ITH.
|
26786868 |
2016 |
Colorectal Carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
CIP4 levels were interrelated to the AKAP-9 level in CRC cells.
|
27039663 |
2016 |
Colorectal Carcinoma
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
One SNP AKAP9 M463I remained significantly associated with CRC risk after stringent adjustment for multiple testing.
|
17000706 |
2006 |
Colorectal Carcinoma
|
0.340 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
We report that EPAC1, PKA, and AKAP9 along with other molecular partners are amplified in breast cancer patients, indicating the importance of this signaling network.
|
28210903 |
2017 |
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Using the Breast Cancer Association Consortium, the authors previously reported that the single nucleotide polymorphism 7q21-rs6964587 (AKAP9-rs6964587" genes_norm="10142">M463I) is associated with breast cancer risk.
|
21931171 |
2011 |
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.
|
18334708 |
2008 |
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Brugada Syndrome (disorder)
|
0.310 |
Biomarker
|
disease |
BEFREE |
Brugada syndrome & AKAP9: Reconciling clinical findings with diagnostic uncertainty.
|
31654968 |
2019 |
Brugada Syndrome (disorder)
|
0.310 |
GeneticVariation
|
disease |
ORPHANET |
The role of clinical, genetic and segregation evaluation in sudden infant death.
|
25016126 |
2014 |
Romano-Ward Syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genotype- and phenotype-guided management of congenital long QT syndrome.
|
24093767 |
2013 |
Dermatologic disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
|
16835338 |
2006 |
Arsenic Poisoning, Inorganic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
|
16835338 |
2006 |
Nervous System, Organic Arsenic Poisoning
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
|
16835338 |
2006 |
Arsenic Poisoning
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
|
16835338 |
2006 |
Arsenic Encephalopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.
|
16835338 |
2006 |